Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
Plugged-In: EV Collision Insights Q3 2025
Do
Business Insurance
Article
Business Insurance Video: Comp Spotlight with Mike Cwynar
Workers' Comp
Article
The Shifting Landscape of Medical Costs: How Workers’ Compensation is Becoming a Payor of Last Resort
As open enrollment season is in full swing and the future of the Affordable Care Act's (ACA) enhanced premium tax credits remain uncertain, employe
Business Insurance
In the News
COVID comp claims keep landing in courts, with trend seen continuing
Workers' Comp
Article
Person-First Support Drives Better Recovery and Return-to-Work Results
Mental health isn’t a side note in workers’ comp anymore.
Workers' Comp
Article
Ask The Pharmacist: What Adjusters Need to Know About Trubrexa, a High-Cost Topical Analgesic
Are private-label topicals like Trubrexa worth the cost in workers’ comp? Private label topical analgesics (PLTAs) continue to push p